10568
20531
ENSG00000157765
ENSMUSG00000029188
O95436
Q9DBP0
NM_006424NM_001177998NM_001177999
NM_011402
NP_001171469NP_001171470NP_006415
NP_035532
Sodium-dependent phosphate transport protein 2B (NaPi2b) is a protein that in humans is encoded by the SLC34A2 gene.
Sodium-dependent phosphate transport protein 2b (NaPi2b) is a tumor-associated antigen.
upifitamab rilsodotin, an antibody-drug conjugate (ADC) targeting NaPi2b, was evaluated in Phase 3 clinical trials for recurrent platinum-sensitive ovarian cancer. The trials were, however, terminated in September of 2023 by the sponsor.